États-Unis · Plateformes & données · Yahoo Finance

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Publié par Yahoo Finance · États-Unis il y a 8 h

Latest $1.5 Million Installment Reflects Continued Milestone Progress as DARE-LARC1 Advances in Preclinical Development Company Exploring Potential Strategic Collaborations for…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

À lire aussi

Gilead Sciences, Inc. (NASDAQ:GILD) Shareholders to Collect $0.82 Quarterly Dividend

AutoNation revenue beats estimates despite decline in vehicle sales

Think You Missed Out on Micron's Run? Think Again.

This one chart tells you everything you need to know about Exxon, Chevron and BP’s forecast-beating earnings

Hilton Grand Vacations announces $200 million accelerated share repurchase

Best Tech Stocks Right Now

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Partager

À lire aussi

Gilead Sciences, Inc. (NASDAQ:GILD) Shareholders to Collect $0.82 Quarterly Dividend

AutoNation revenue beats estimates despite decline in vehicle sales

Think You Missed Out on Micron's Run? Think Again.

This one chart tells you everything you need to know about Exxon, Chevron and BP’s forecast-beating earnings

Hilton Grand Vacations announces $200 million accelerated share repurchase

Best Tech Stocks Right Now